Frost & Sullivan talks life science analysis
Nandhini Rajagopal, industry analyst, Frost & Sullivan, talks about medical market analysis and development
Consumer concern for holistic health has augmented the demand for preventive healthcare.
Frost & Sullivan’s dedicated Global Food, Drugs and Cosmetics (FDC) Program makes informed strategic and tactical decisions based on robust and accurate insight.
Our research services understand the dynamically changing trends in medical world.
The value at stake in understanding these longterm perspectives is significant. The output of the platform is a series of specific market studies, insightful presentations, and interactive workshops.
Globalisation has influenced significant lifestyle changes in the developing nations of the world. It has also led to the rise of a high income group which thereby leads to changing patterns of food consumption.
Our research services helps to understand the polymers used in medical devices.
We also deep dive into the pharmaceutical sector with expertise in APIs and excipient. An average drug loses up to 36.0% of sales due to non-medical adherence.
We at Frost & Sullivan analyse the disease state, unique characteristics of the market and geographic trends to develop insights on developing smart and functional packaging.
As I am a social worker helping at hospitals, my exposure to medical devices are little more than a normal person.
Medical devices are used in catheters that are used in RT feeds, IV fluids, and bladder output. Single disposable syringes used for injections and also at times for measurements. Fluid bags are also key products that I come across.
Statistical data clearly states death of 125,000 people in US due to prescribed medicine non-adherence. Moreover, poor medical adherence also doubles patients spending.
Hence, pharmaceutical packaging can easily become $300 billion opportunity to improve the medical adherence drive.
Focusing on new drug delivery systems and connected health will be the next money spinners in this market.